HCPCS Level II drug code
Q9992 — Injection, buprenorphine extended-release (sublocade), greater than 100 mg
In short
Q9992 is the HCPCS Level II code for injection, buprenorphine extended-release (sublocade), greater than 100 mg. CMS assigns NDCs for Sublocade to it. The Medicare Part B payment limit is $2,060.132 per unit (October 1, 2026 through December 31, 2026).
Code
CMS HCPCS file- Descriptor
- Injection, buprenorphine extended-release (sublocade), greater than 100 mg
- Short descriptor
- Buprenorphine xr over 100 mg
- Code set
- HCPCS Level II, maintained by CMS
- Effective
- Jul 1, 2018
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Units and claim line
Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.
Enter the units to build the claim line.
NDCs billed under Q9992
CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 1 NDC to Q9992 for Sublocade. Billing units per package are CMS’s figures for this code’s unit.
| Drug | NDC (11-digit) | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| Sublocade | 12496-0300-01 | Indivior Inc. | 1.5 | 1 |
Q9992: common questions
- Is Q9992 a CPT code?
- No. Q9992 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
- What NDCs are billed under Q9992?
- CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 1 NDC under Q9992, for Sublocade. The table on this page shows each one with its billing units per package.
- What is the Medicare payment limit for Q9992?
- $2,060.132 per greater than 100 mg, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.